ASIC1-Mediated Calcium Entry Stimulates NFATc3 Nuclear Translocation via PICK1 Coupling in Pulmonary Arterial Smooth Muscle Cells
AJP Lung Cellular and Molecular Physiology
Published online on May 17, 2016
Abstract
The development of chronic hypoxia (CH)-induced pulmonary hypertension is associated with increased pulmonary arterial smooth muscle cell (PASMC) Ca2+ influx through acid sensing ion channel 1 (ASIC1) and activation of the Ca2+/calcineurin-dependent transcription factor, nuclear factor of activated T-cells isoform c3 (NFATc3). Whether Ca2+-influx through ASIC1 contributes to NFATc3 activation in the pulmonary vasculature is unknown. Furthermore, both ASIC1 and calcineurin have been shown to interact with the scaffolding protein, protein interacting with C kinase 1 (PICK1). In the present study, we tested the hypothesis that ASIC1 contributes to NFATc3 nuclear translocation in PASMC in a PICK1-dependent manner. Using both ASIC1 knockout (ASIC1-/-) mice and pharmacological inhibition of ASIC1, we demonstrate ASIC1 contributes to CH (1 wk @ 380 mmHg) and endothelin-1 (ET-1; 10-7 M) induced Ca2+ responses and NFATc3 nuclear import in PASMC. The interaction between ASIC1/PICK1/calcineurin was shown using Duolink in situ proximity ligation assay. Inhibition of PICK1, using FSC231, abolished ET-1- and ionomycin-induced NFATc3 nuclear import, but did not alter ET-1-mediated Ca2+ responses suggesting that PICK1 acts downstream of Ca2+ influx. The key findings of the present work are that 1) Ca2+ influx through ASIC1 mediates CH- and ET-1-induced NFATc3 nuclear import and 2) the scaffolding protein, PICK1, is necessary for NFATc3 nuclear import. Together these data provide an essential link between CH-induced ASIC1-mediated Ca2+ influx and activation of the NFATc3 transcription factor. Identification of this ASIC1/PICK1/NFATc3 signaling complex increases our understanding of the mechanisms contributing to the vascular remodeling and increased vascular contractility associated with CH-induced pulmonary hypertension.